Sorafenib targets several enzymes involved in cell growth as well as the formation of new blood vessels triggered by the tumor itself, which tumors use to ensure their supply of oxygen and nutrients.

Sorafenib is an oral multikinase inhibitor that inhibits tumor growth and proliferation by interfering with several receptor tyrosine kinases involved in the pathogenesis and perpetuation of ...